Published in J Pharmacol Exp Ther on October 01, 2000
Antifungal activity of phenyllactic acid against molds isolated from bakery products. Appl Environ Microbiol (2003) 1.26
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest (2003) 0.90
The lactic acid bacteria metabolite phenyllactic acid inhibits both radial growth and sporulation of filamentous fungi. BMC Res Notes (2013) 0.81
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature (1998) 3.84
Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron (1997) 3.27
Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics (2000) 1.79
A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology (1998) 1.52
Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem (1989) 1.42
Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett (1995) 1.22
Neurotoxicity of domoic Acid in cerebellar granule neurons in a genetic model of glutathione deficiency. Mol Pharmacol (2006) 1.18
Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem Biol Interact (1993) 1.14
Maturation-dependent effects of chlorpyrifos and parathion and their oxygen analogs on acetylcholinesterase and neuronal and glial markers in aggregating brain cell cultures. Toxicol Appl Pharmacol (2000) 1.12
Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells. Eur J Pharmacol (1996) 1.12
Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health (1993) 1.10
Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect (1998) 1.10
Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact (2010) 1.09
Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Neurotoxicology (2000) 1.05
Neuropsychological performance among agricultural pesticide applicators. Environ Res (1992) 1.04
A pilot study of occupational and environmental risk factors for Parkinson's disease. Neurotoxicology (1991) 1.01
Nutrition and alcohol neurotoxicity. Neurotoxicology (1994) 0.98
Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol Appl Pharmacol (1991) 0.97
Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. Toxicol Appl Pharmacol (2004) 0.95
Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis (1995) 0.94
Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression. Free Radic Biol Med (2013) 0.93
Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: role in DNA synthesis and effect of ethanol. Glia (2001) 0.93
Inhibition of muscarinic receptor-stimulated glial cell proliferation by ethanol. J Neurochem (1996) 0.93
Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1992) 0.90
Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis (2009) 0.90
Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. Chem Res Toxicol (1992) 0.90
Apoptosis induced by domoic acid in mouse cerebellar granule neurons involves activation of p38 and JNK MAP kinases. Neurochem Int (2007) 0.89
A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen. Neuropharmacology (1985) 0.89
Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. Pharmacogenetics (1997) 0.89
Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet (1997) 0.89
Effects of ethanol on calcium homeostasis in the nervous system: implications for astrocytes. Mol Neurobiol (1999) 0.89
Cholesterol homeostasis in the developing brain: a possible new target for ethanol. Hum Exp Toxicol (2007) 0.88
Nuclear factor kappaB activation by muscarinic receptors in astroglial cells: effect of ethanol. Neuroscience (2003) 0.87
Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol (1996) 0.87
Exposure to 60-Hz magnetic fields and proliferation of human astrocytoma cells in vitro. Toxicol Appl Pharmacol (2000) 0.87
Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats. Fundam Appl Toxicol (1993) 0.86
Possible role of protein kinase C zeta in muscarinic receptor-induced proliferation of astrocytoma cells. Biochem Pharmacol (2000) 0.86
Effects of trimethyltin on granule cells excitability in the in vitro rat dentate gyrus. Neurotoxicol Teratol (1987) 0.85
Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. J Pharmacol Exp Ther (1987) 0.84
Effects of inorganic and organic mercury on intracellular calcium levels in rat T lymphocytes. J Toxicol Environ Health (1993) 0.84
Tolerance to anticholinesterase compounds in mammals. Toxicology (1982) 0.84
Mechanisms of neurotoxicity: applications to human biomonitoring. Toxicol Lett (1995) 0.83
Quantitative measurements of vibration threshold in healthy adults and acrylamide workers. Int Arch Occup Environ Health (1993) 0.83
Muscarinic receptors prevent oxidative stress-mediated apoptosis induced by domoic acid in mouse cerebellar granule cells. J Neurochem (2009) 0.83
Activation of phosphatidylinositol 3 kinase by muscarinic receptors in astrocytoma cells. Neuroreport (2001) 0.83
Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 0.83
Identification of m3, m4 and m5 subtypes of muscarinic receptor mRNA in human blood mononuclear cells. J Neuroimmunol (1995) 0.83
Peripheral markers of neurochemical function among workers exposed to styrene. Br J Ind Med (1992) 0.83
3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes. Immunopharmacology (1992) 0.83
Factors involved in the differential acute toxicity of the insecticides chlorpyrifos and methyl chlorpyrifos in mice. Toxicol Appl Pharmacol (1982) 0.83
Linear versus nonlinear models for hemoglobin adduct formation by acrylamide and its metabolite glycidamide: implications for risk estimation. Cancer Epidemiol Biomarkers Prev (1993) 0.83
Behavioral and biochemical effects of postnatal parathion exposure in the rat. Neurotoxicol Teratol (1989) 0.82
Thyroid peroxidase as toxicity target for dithiocarbamates. Arch Toxicol (1997) 0.82
Effects of the muscarinic agonist oxotremorine on membrane fluidity in rat lymphocytes. Biochem Mol Biol Int (1993) 0.82
Genetic polymorphisms in Parkinson's disease. Neurotoxicology (1998) 0.82
Effects of ethanol administration on cerebral non-protein sulfhydryl content in rats exposed to styrene vapour. Toxicology (1996) 0.82
Muscarinic cholinergic receptor signal transduction as a potential target for the developmental neurotoxicity of ethanol. Biochem Pharmacol (1999) 0.82
Signal transduction mechanisms involved in the antiproliferative effects of ethanol in glial cells. Toxicol Lett (2004) 0.82
Organophosphate pesticide exposure in a group of Washington State orchard applicators. Environ Res (1992) 0.82
Na+/K(+)-ATPase in rat brain and erythrocytes as a possible target and marker, respectively, for neurotoxicity: studies with chlordecone, organotins and mercury compounds. Toxicol Lett (1990) 0.81
Developmental neurotoxicity: do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuria. Toxicol Lett (2002) 0.81
Use of aggregating brain cell cultures to study developmental effects of organophosphorus insecticides. Neurotoxicology (2000) 0.81
Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development. J Pharmacol Exp Ther (1989) 0.80
The PON1 gene and detoxication. Neurotoxicology (2000) 0.80
Transplantation for acute liver failure in children. Transplant Proc (2005) 0.80
Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells. J Toxicol Environ Health (1994) 0.80
The role of protein kinase C alpha and epsilon isozymes in DNA synthesis induced by muscarinic receptors in a glial cell line. Eur J Pharmacol (1998) 0.80
Muscarinic receptor-induced calcium responses in astroglia. Cytometry (2000) 0.80
Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism. J Neurol Neurosurg Psychiatry (2000) 0.80
Effects of thallium on primary cultures of testicular cells. J Toxicol Environ Health (1992) 0.80
Synergistic interactions between PBDEs and PCBs in human neuroblastoma cells. Environ Toxicol (2012) 0.80
Modulation of DNA synthesis by muscarinic cholinergic receptors. Growth Factors (2001) 0.80
Developmental neurotoxicity of ethanol: further evidence for an involvement of muscarinic receptor-stimulated phosphoinositide hydrolysis. Eur J Pharmacol (1994) 0.80
Ethanol selectively interferes with the trophic action of NMDA and carbachol on cultured cerebellar granule neurons undergoing apoptosis. Brain Res Dev Brain Res (1998) 0.79
Calcium entry blockade as a mechanism for chlordimeform-induced inhibition of motor activity in the isolated guinea-pig ileum. Pharmacol Toxicol (1992) 0.79
Interaction of choline with nicotinic and muscarinic cholinergic receptors in the rat brain in vitro. Clin Exp Pharmacol Physiol (1985) 0.79
Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism. Neurotoxicology (1998) 0.79
Modulation of M1 and M2 muscarinic receptor subtypes following repeated organophosphate exposure in rats. Toxicol Appl Pharmacol (1992) 0.79
Platelet monoamine oxidase B activity in workers exposed to styrene. Int Arch Occup Environ Health (1994) 0.79
Inorganic lead stimulates DNA synthesis in human astrocytoma cells: role of protein kinase Calpha. J Neurochem (2001) 0.79
Intracellular signal transduction pathways as targets for neurotoxicants. Toxicology (2001) 0.79
Time-, concentration-, and age-dependent inhibition of muscarinic receptor-stimulated phosphoinositide metabolism by ethanol in the developing rat brain. Neurochem Res (1991) 0.79
Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain. Neurotoxicology (1997) 0.79
A nonlinear dosimetric model for hemoglobin adduct formation by the neurotoxic agent acrylamide and its genotoxic metabolite glycidamide. Environ Health Perspect (1993) 0.79
Pediatric split liver transplantation using elderly donors. Transplant Proc (2001) 0.79
Biomarkers in environmental medicine: alterations of cell signalling as early indicators of neurotoxicity. Funct Neurol (1994) 0.79
Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides. Biochem Pharmacol (1982) 0.78
Specific binding of [3H]methylscopolamine to glass fibre filters. J Pharm Pharmacol (1987) 0.78
Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol Appl Pharmacol (1993) 0.78
Liver transplantation in children weighting less than 6 kg: the Bergamo experience. Transplant Proc (2005) 0.78
Effect of trimethyltin on chemically-induced seizures. Toxicol Lett (1982) 0.78
Lymphocyte beta-adrenoceptors, asthma, and ethnicity. Lancet (1992) 0.78
Expression of cholinergic muscarinic receptor subtypes mRNA in rat blood mononuclear cells. Immunopharmacology (1995) 0.78
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. Transplant Proc (2005) 0.78
A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure. Brain Res (1983) 0.78
Orthotopic liver transplantation for biliary atresia. Transplant Proc (2005) 0.78